HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quan Jiang Selected Research

Embolic Stroke

1/2021Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA.
4/2014Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.
12/2011Longitudinal magnetic resonance imaging of sildenafil treatment of embolic stroke in aged rats.
3/2011Mean microvessel segment length and radius after embolic stroke: Comparison of magnetic resonance imaging (MRI) and laser scanning confocal microscopy (LSCM).
11/2010Cerebral tissue repair and atrophy after embolic stroke in rat: a magnetic resonance imaging study of erythropoietin therapy.
8/2008Magnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafil-treated rats.
5/2008Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI.
2/2007Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke.
11/2006Ischemic cerebral tissue response to subventricular zone cell transplantation measured by iterative self-organizing data analysis technique algorithm.
10/2006Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Quan Jiang Research Topics

Disease

25Stroke (Strokes)
01/2022 - 08/2002
18Neoplasms (Cancer)
08/2021 - 09/2004
18Embolic Stroke
01/2021 - 05/2002
16Rheumatoid Arthritis
02/2022 - 12/2009
10Ischemia
01/2018 - 08/2002
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019 - 04/2011
5Stomach Neoplasms (Stomach Cancer)
09/2021 - 01/2021
5Inflammation (Inflammations)
01/2021 - 11/2005
4Pain (Aches)
09/2021 - 10/2013
4Type 2 Diabetes Mellitus (MODY)
08/2017 - 09/2014
4Ankylosing Spondylitis
01/2017 - 10/2013
4Breast Neoplasms (Breast Cancer)
06/2013 - 08/2010
4Atrophy
11/2012 - 11/2010
3Thyroid Nodule (Nodule, Thyroid)
08/2022 - 10/2021
3Fibromyalgia (Fibrositis)
09/2021 - 11/2019
3Thrombosis (Thrombus)
01/2021 - 11/2005
3Ischemic Stroke
01/2021 - 08/2004
3Carcinogenesis
01/2021 - 08/2010
3Brain Injuries (Brain Injury)
01/2021 - 06/2015
3Arthritis (Polyarthritis)
01/2019 - 12/2009
3Brain Ischemia (Cerebral Ischemia)
04/2014 - 08/2004
3Infarction (Infarctions)
04/2014 - 02/2002
2Hemorrhage
01/2022 - 10/2006
2Rheumatic Diseases (Rheumatism)
01/2022 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2021 - 02/2013
2Body Weight (Weight, Body)
01/2020 - 03/2009
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2019 - 04/2017
2Carotid Artery Diseases
08/2017 - 09/2014
2Glioma (Gliomas)
01/2012 - 03/2006
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2009 - 11/2005
1Neuroinflammatory Diseases
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Hyperplasia
12/2021
1Microsatellite Instability
08/2021
1Adenocarcinoma
08/2021
1Genomic Instability
08/2021

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2015
7Tissue Plasminogen Activator (Alteplase)FDA Link
04/2015 - 08/2002
6Contrast MediaIBA
04/2017 - 09/2004
5Therapeutic UsesIBA
09/2021 - 11/2012
5Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2015
5Gadolinium DTPA (Magnevist)FDA Link
04/2017 - 08/2002
4MicroRNAs (MicroRNA)IBA
01/2021 - 05/2015
4qingre huoxueIBA
01/2021 - 12/2011
4GlycosidesIBA
10/2020 - 01/2018
4TabletsIBA
10/2020 - 01/2018
4Sildenafil Citrate (Viagra)FDA Link
12/2011 - 02/2007
32-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
08/2022 - 10/2021
3Neuroprotective AgentsIBA
01/2022 - 11/2005
3Indicators and Reagents (Reagents)IBA
01/2021 - 01/2016
3LipidsIBA
01/2020 - 11/2009
3Pharmaceutical PreparationsIBA
01/2018 - 11/2012
3FibrinIBA
04/2015 - 01/2005
3von Willebrand FactorIBA
12/2008 - 02/2002
2Biological ProductsIBA
02/2022 - 01/2021
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 07/2019
2AlbuminsIBA
01/2022 - 03/2006
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022 - 01/2021
2Peptides (Polypeptides)IBA
01/2022 - 04/2014
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2021
2Long Noncoding RNAIBA
09/2021 - 08/2021
2AutoantibodiesIBA
01/2021 - 05/2019
2oxidized low density lipoproteinIBA
01/2021 - 09/2014
2bushen qiangjiIBA
11/2016 - 10/2013
2C-Reactive ProteinIBA
01/2016 - 10/2013
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2015 - 11/2005
2GadoliniumIBA
02/2015 - 05/2002
2daidzeinIBA
08/2014 - 08/2010
2Estrogens (Estrogen)FDA Link
02/2014 - 08/2010
2TamoxifenFDA LinkGeneric
06/2013 - 04/2012
2Estrogen ReceptorsIBA
06/2013 - 04/2012
2IronIBA
01/2012 - 01/2012
2ErythropoietinFDA Link
11/2010 - 03/2009
2ferumoxides (Feridex)FDA Link
09/2007 - 08/2007
2Protamines (Protamine Sulfate)FDA Link
09/2007 - 08/2007
2Protons (Proton)IBA
10/2006 - 05/2005
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2006 - 11/2005
2Atorvastatin (Lipitor)FDA Link
07/2006 - 11/2005
1Apoprotein(a) (Apolipoprotein (a))IBA
01/2022
1Toll-Like Receptor 4IBA
01/2022
1Insulin-Like PeptidesIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2022
1Mitogen-Activated Protein Kinase 3IBA
12/2021
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2021
1Capsules (Microcapsules)IBA
09/2021
1Pregabalin (Lyrica)FDA Link
09/2021
1NucleotidesIBA
08/2021
1RNA (Ribonucleic Acid)IBA
08/2021

Therapy/Procedure

21Therapeutics
09/2021 - 02/2003
7Transplantation
01/2019 - 02/2003
6Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 07/2016
6Thrombolytic Therapy
04/2015 - 01/2005
3Drug Therapy (Chemotherapy)
08/2021 - 08/2018
3Aftercare (After-Treatment)
01/2016 - 11/2005
3Lasers (Laser)
09/2015 - 11/2005
3Cell- and Tissue-Based Therapy (Cell Therapy)
04/2011 - 02/2003
2Neoadjuvant Therapy
08/2018 - 10/2010